Biotech · Private company
Tyrogenex
Track this companyFree. Adds Tyrogenex to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Anti-VEGFPhase 2 · Age-Related Macular Degeneration (AMD)ClinicalTrials.gov · fetched Nov 12, 2026
- X-82Phase 2 · Age-Related Macular Degeneration (AMD)ClinicalTrials.gov · fetched Nov 12, 2026
- X-82Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- X-82 to Treat Age-related Macular DegenerationPHASE2 · TERMINATED · started Mar 16, 2015ClinicalTrials.gov NCT02348359 · fetched Nov 12, 2026
- Safety Study of X-82 in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Feb 1, 2011ClinicalTrials.gov NCT01296581 · fetched Nov 12, 2026